Anuh Pharma Limited (BOM:506260)
India · Delayed Price · Currency is INR 82.12
-0.87 (-1.05%)
At close: Feb 12, 2026
Anuh Pharma Revenue
Anuh Pharma had revenue of 1.97B INR in the quarter ending December 31, 2025, with 23.61% growth. This brings the company's revenue in the last twelve months to 7.68B, up 22.39% year-over-year. In the fiscal year ending March 31, 2025, Anuh Pharma had annual revenue of 6.62B with 2.24% growth.
Revenue (ttm)
7.68B
Revenue Growth
+22.39%
P/S Ratio
1.06
Revenue / Employee
26.02M
Employees
295
Market Cap
8.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.62B | 145.11M | 2.24% |
| Mar 31, 2024 | 6.47B | 1.20B | 22.66% |
| Mar 31, 2023 | 5.27B | 408.40M | 8.39% |
| Mar 31, 2022 | 4.87B | 546.86M | 12.66% |
| Mar 31, 2021 | 4.32B | 1.25B | 40.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Venus Remedies | 7.03B |
| Wanbury | 6.58B |
| Sudarshan Pharma Industries | 6.44B |
| Lincoln Pharmaceuticals | 6.32B |
| Kopran | 6.20B |
| Fredun Pharmaceuticals | 5.91B |
| Fermenta Biotech | 5.44B |
| Kwality Pharmaceuticals | 4.23B |
Anuh Pharma News
- 2 months ago - Anuh Pharma Secures EDQM Certificate of Suitability for Sulfadimethoxine - Business Upturn
- 7 months ago - Anuh Pharma inaugurates new manufacturing block to boost capacity by 200 MT annually - Business Upturn